PAPADOPOULOS STELIOS

CIK 000120209810 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001202098

Recent Transactions

50 trades

Award
Ovid Therapeutics Inc.$OVID
Employee Stock Option (Right to Buy)
2026-02-26+65,000→ 65,000 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-11-12$43.55/sh−100,000→ 1,189,228 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−60,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−30,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−2,325→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−30,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Common Stock Purchase Warrant (Right to Buy)
2025-06-25−59,514→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−4,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−9,000→ 0 total
Disposition from Tender
Regulus Therapeutics Inc.
Common Stock
2025-06-25−976,253→ 64,635 total
Disposition to Issuer
Regulus Therapeutics Inc.
Common Stock
2025-06-25−64,635→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−4,650→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−15,000→ 0 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2025-05-29+9,812→ 1,289,228 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-05-15$44.35/sh−20,634→ 1,279,416 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-05-15−15,874→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-05-15$44.35/sh−15,874→ 1,279,416 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-05-15−20,634→ 0 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2025-05-15$20.50/sh+15,874→ 1,295,290 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2025-05-15$19.77/sh+20,634→ 1,300,050 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-04-30+62,500→ 1,040,888 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (right to buy)
2025-03-03+90,000→ 90,000 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2024-05-31+18,838→ 1,279,416 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-20+60,000→ 60,000 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2024-05-20$21.00/sh−11,437→ 1,260,578 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2024-05-20$19.57/sh+11,686→ 1,272,015 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2024-05-20−11,686→ 0 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-16+30,000→ 30,000 total
Award
Regulus Therapeutics Inc.
Common Stock
2024-03-14$1.60/sh+250,000→ 978,388 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-08-10+15,000→ 15,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-06-13+30,000→ 30,000 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2023-06-01+20,718→ 1,260,329 total
Award
Regulus Therapeutics Inc.
Common Stock
2023-04-13$0.90/sh+222,198→ 728,388 total
Award
BIOGEN INC.$BIIB
Common Stock
2022-06-15+2,255→ 10,095 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2022-06-09+90,000→ 90,000 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2022-05-26+19,575→ 1,239,611 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2022-02-22$19.56/sh−84,515→ 1,220,036 total
Award
Regulus Therapeutics Inc.
Common Stock
2021-11-30$0.36/sh+2,222,222→ 5,061,929 total
Award
BIOGEN INC.$BIIB
Common Stock
2021-07-01+1,275→ 7,840 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2021-06-14+40,000→ 40,000 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2021-05-27+16,424→ 1,304,551 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2021-05-11$3.13/sh+40,000→ 1,258,675 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2021-05-11$24.95/sh−10,222→ 1,218,675 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2021-05-11$6.30/sh+40,000→ 1,228,897 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2021-05-11−40,000→ 0 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2021-05-11−40,000→ 0 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2021-05-11−40,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2021-05-11$25.01/sh−5,473→ 1,288,127 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2021-05-11$3.38/sh+40,000→ 1,293,600 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2021-05-11$25.00/sh−5,075→ 1,253,600 total

Companies

Recent Filings

Address

C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE, 14TH FLOOR

NEW YORK, NY, 10001

View on SEC.gov